Phase 3: Rapid Relief in Thyroid Eye Disease With Veligrotug

A five-infusion course of veligrotug is well tolerated and results in rapid improvements in diplopia, proptosis, and disease activity in patients with thyroid eye disease, a phase 3 trial shows.
Medscape Medical News

source https://www.medscape.com/viewarticle/phase-3-rapid-relief-thyroid-eye-disease-veligrotug-2026a1000ifw?src=rss